KLAY Biotech is an advanced AI-powered software platform designed specifically to support craniofacial and reconstructive surgery. Developed in close collaboration with leading surgeons, KLAY is transforming how complex cases are planned, visualised and delivered — improving accuracy, predictability and patient outcomes.
KLAY Biotech
Advancing craniofacial surgery through AI-driven planning and precision.
Clinically Led by World-Leading Surgeons
KLAY Biotech is not theoretical or detached from clinical reality — it is actively shaped and refined by surgeons working at the forefront of craniofacial care.
Professor David Dunaway and Professor Owase Jeelani are directly involved in both the development and real-world clinical application of KLAY. Their hands-on experience with complex craniofacial and neurosurgical cases ensures the platform addresses genuine surgical challenges, not abstract technical problems.
By contributing clinical insight, case-based feedback and surgical perspective, they help guide how KLAY evolves — from how anatomy is analysed, to how planning tools are structured and applied in practice. This close collaboration ensures the technology remains practical, precise and relevant to modern craniofacial surgery.
Plastic & Craniofacial Surgeon
Professor David Dunaway
Bringing decades of experience in complex Craniofacial and reconstructive surgery.
Consultant Paediatric Neurosurgeon
Professor Owase Jeelani
Professor Owase Jeelani is a Consultant Paediatric Neurosurgeon and has worked at Great Ormand Street Hospital for Children (GOSH) part...
How KLAY Works
KLAY uses advanced algorithms to process patient imaging data and create highly detailed, intelligent surgical models.
AI-assisted analysis of craniofacial anatomy
Enhanced 3D visualisation for complex structures
Support for pre-operative planning and simulation
Improved accuracy in surgical decision-making
Consistent, reproducible planning across cases
Purpose-Built for Craniofacial Surgery
KLAY is informed by real clinical needs, with the goal of improving surgical accuracy, safety and outcomes for patients facing complex craniofacial conditions.
Craniofacial procedures demand exceptional precision, forward planning and multidisciplinary coordination. KLAY has been developed to meet these exact challenges, using artificial intelligence to support complex decision-making and surgical preparation.
The platform enables surgeons to analyse anatomy in greater detail, plan interventions with confidence and anticipate outcomes before entering the operating theatre.
Driving the Future of Craniofacial Care
KLAY represents a new generation of surgical technology — combining artificial intelligence, clinical expertise and innovation to push the boundaries of what is possible in Craniofacial surgery.
Through continued collaboration between surgeons and technologists, KLAY is helping shape the future of safer, smarter and more precise Craniofacial care.
